Northwest Biotherapeutics, Inc. (OTCMKTS:NWBO – Get Free Report)’s stock price passed below its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of $0.28 and traded as low as $0.23. Northwest Biotherapeutics shares last traded at $0.25, with a volume of 3,969,233 shares traded.
Northwest Biotherapeutics Stock Up 7.2 %
The company has a 50 day moving average of $0.26 and a 200 day moving average of $0.28. The firm has a market cap of $347.65 million, a price-to-earnings ratio of -3.15 and a beta of -0.52.
About Northwest Biotherapeutics
Northwest Biotherapeutics, Inc, a biotechnology company, develops personalized immune therapies for cancer in the United States and internationally. The company develops its products based on DCVax, a platform technology that uses activated dendritic cells to mobilize a patient’s own immune system to attack cancer.
Recommended Stories
- Five stocks we like better than Northwest Biotherapeutics
- The Significance of a Trillion-Dollar Market Cap Goes Beyond a Number
- FedEx Delivers Another Crushing Blow to Its Stock Price
- What is the FTSE 100 index?
- Analysts Stay Bullish on Rocket Lab as Signs of a Bottom Emerge
- With Risk Tolerance, One Size Does Not Fit All
- Micron Stock Will Retest All-Time Highs This Year
Receive News & Ratings for Northwest Biotherapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Northwest Biotherapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
